drugset / Trial / NCT02130531

Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

NCT02130531 ↗

Phase 1 Completed 26 enrolled Kubota Vision Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to characterize emixustat hydrochloride pharmacokinetic and pharmacodynamic parameters in subjects with geographic atrophy associated with dry age-related macular degeneration.

Timeline

Start
2014-04
Primary completion
2015-09
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Emixustat Small molecule — Oral